S29 Neuroendocrine Control: Is It All in Your Brain?

Program: Symposia
Basic Session
Saturday, April 2, 2016: 8:15 AM-9:45 AM
Room 107 (BCEC)
Chair:
Martin J Kelly, PhD, Oregon Health & Science University, Portland, OR

Nothing to Disclose: MJK
8:15 AM
Suzanne M Moenter, PhD, Dept. Mol Integrative Physiol, University of Michigan, Ann Arbor, MI
Nothing to Disclose: SMM
8:45 AM
Allan Edward Herbison, MD, PhD, Centre for Neuroendocrinology, University of Otago, Dunedin, New Zealand
Nothing to Disclose: AEH
9:15 AM
Iain J Clarke, PhD, Dept of Physiology, Monash University, Clayton, Australia
Nothing to Disclose: IJC
See more of: Symposia

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire